Pelthos Therapeutics Inc. - PTHS
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2026
· Q2 2026
Value (USD)
Total reported value ($000)
$37.38M
QoQ value delta ($000)
-$1K
(-0.0%)
Implied price effect (QoQ)
-0.0%
Shares
Total shares
1,323,163
QoQ shares delta
0
(0.0%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (PTHS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2026)
Top 25 only
Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| AIGH Capital Management LLC | 9,300 | 329,098 | 0.59% |
| Murchinson Ltd. | 8,599 | 304,302 | 1.19% |
| Ikarian Capital, LLC | 7,251 | 256,598 | 0.78% |
| BOOTHBAY FUND MANAGEMENT, LLC | 2,881 | 101,976 | 0.04% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,745 | 97,134 | 0.0% |
| CANTOR FITZGERALD, L. P. | 1,077 | 38,123 | 0.01% |
| J. Goldman & Co LP | 1,076 | 38,075 | 0.03% |
| DIADEMA PARTNERS LP | 700 | 24,773 | 0.09% |
| WEXFORD CAPITAL LP | 632 | 22,364 | 0.08% |
| Knott David M Jr | 623 | 22,073 | 0.33% |
| CITADEL ADVISORS LLC | 425 | 15,046 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 414 | 14,650 | 0.0% |
| Pale Fire Capital SE | 365 | 12,919 | 0.03% |
| 1492 Capital Management LLC | 293 | 10,380 | 0.09% |
| VANGUARD FIDUCIARY TRUST CO | 279 | 9,873 | 0.0% |
| STATE STREET CORP | 276 | 9,800 | 0.0% |
| Persistent Asset Partners Ltd | 169 | 6,007 | 0.05% |
| BlackRock, Inc. | 150 | 5,324 | 0.0% |
| UBS Group AG | 62 | 2,217 | 0.0% |
| China Universal Asset Management Co., Ltd. | 61 | 2,160 | 0.0% |
| Tower Research Capital LLC (TRC) | 5 | 205 | 0.0% |
| BARCLAYS PLC | 0 | 20 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 6 | 0.0% |
| Farther Finance Advisors, LLC | 0 | 40 | 0.0% |